Overcoming triple mutant EGFR-tyrosine kinase barriers in the therapeutics of non-small cell lung cancer: a patent review on fourth-generation inhibitors (2017–2024)
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-07-30 21:33:41 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1080/13543776.2025.2536006
文献链接: https://www.tandfonline.com/doi/full/10.1080/13543776.2025.2536006
其他信息:
出版社: Informa UK Limited
作者: Narendra R. Nagpure; Harun M. Patel